相关实验视频
Updated: May 1, 2026

10:35
Stereotactic Radiosurgery for Gynecologic Cancer
Published on: April 17, 2012
18.0K
针对妇科癌症的手臂治疗中可注射的生物吸收间隔剂:范围审查
Carminia Lapuz1,2, Mollie Kain1, Michael Chao1,2
1Department of Radiation Oncology, Austin Health, Melbourne, Victoria, Australia.
Journal of contemporary brachytherapy
|February 13, 2025
概括
可注射生物吸收的间隔剂通过减少对附近器官的辐射剂量来改善妇科癌症支架疗法. 需要进一步的研究来证实它们的有效性和患者的结果.
科学领域:
- 在瘤学瘤学.
- 医学物理 医学物理
- 辐射疗法 辐射疗法
背景情况:
- 支臂疗法是妇科癌症的关键治疗方法.
- 优化治疗比率对于最大限度地控制瘤并最大限度地减少副作用至关重要.
- 可以注射的间隔器可以通过在瘤和有风险的器官之间建立隔离来增强辐射输送.
研究的目的:
- 审查现有的关于在妇科癌症支臂治疗中使用注射生物吸收间隔器的文献.
- 评估这些间隔器的安全性,可行性和临床影响.
主要方法:
- 在Embase,PubMed,Medline和Cochrane控制试验中央登记处进行了全面的文献搜索.
- 包括在内科手腕治疗中使用可注射生物吸收间隔器的研究.
- 数据提取侧重于间隔器特性,安全性,剂量测量改进和临床结果.
主要成果:
- 分析了包括312名患者在内的17项研究,主要关注宫癌支臂治疗.
- 在使用的八种不同产品中,没有报告与间隔器相关的显著不良影响.
- 间隔器显示出降低直肠和西格腺剂量的潜力,并使瘤剂量升级.
结论:
- 可注射生物吸收的间隔剂代表了改善妇科手腕治疗中治疗比率的有希望的策略.
- 目前的证据的确定性很低,强调需要高质量的前性研究.
- 进一步的研究应该集中在评估患者报告的结果和成本效益.
更多相关视频
04:04Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
10.4K
12:57X-Ray Visualization of Intraductal Ethanol-Based Ablative Treatment for Prevention of Breast Cancer in Rat Models
Published on: December 9, 2022
2.3K
相关概念视频
Parenteral Drug Delivery Systems: Injectables, Implants, and Infusion Devices
208
Parenteral drug delivery systems play a crucial role in modern therapeutics by enabling the direct administration of drugs into the systemic circulation, bypassing the gastrointestinal tract. These systems are particularly valuable for poorly absorbed oral medications that are unstable in the digestive environment or require rapid onset or sustained therapeutic levels. Delivery is achieved through intravenous, intramuscular, or subcutaneous routes, each selected based on the drug's properties...
208
Intrauterine Drug Delivery Systems
168
Controlled-release systems for intravaginal and intrauterine drug delivery have been developed primarily for the administration of contraceptive steroid hormones. These delivery routes circumvent first-pass hepatic metabolism, thereby enhancing bioavailability and allowing for reduced systemic dosages compared to oral administration. Such approaches contribute to improved therapeutic efficacy and patient compliance, particularly in long-term contraceptive regimens.Intravaginal Drug Delivery...
168